Just very quickly, in terms of this massive study that's being undertaken looking at all the different research—I think you said globally, Dr. Krewski, and I think you said it would be completed in March 2013, and I don't know how long your funding goes—what is anticipated after that, in terms of follow-through, particularly from a funding point of view? How does that keep up to date?
I have the sense that things are moving quickly, that there are new developments, although I don't know that because I don't have it relative to any other either neurological or other diseases. You gave the impression that things are moving quickly.
How do we actually keep up that data? Maybe by next year there will be a whole bunch of things, and by the time you've caught up there will be new things happening. So could you tell us what the follow-through is?